National Academies Press: OpenBook
Suggested Citation:"Front Matter." Institute of Medicine. 1999. Enhancing the Regulatory Decision-Making Approval Process for Direct Food Ingredient Technologies. Washington, DC: The National Academies Press. doi: 10.17226/9453.
×

Enhancing the Regulatory Decision-Making Approval Process for Direct Food Ingredient Technologies

Workshop Summary

Food Forum

Food and Nutrition Board

Institute of Medicine

National Academy Press
Washington, D.C.
1999

Suggested Citation:"Front Matter." Institute of Medicine. 1999. Enhancing the Regulatory Decision-Making Approval Process for Direct Food Ingredient Technologies. Washington, DC: The National Academies Press. doi: 10.17226/9453.
×

National Academy Press
2101 Constitution Avenue, N.W. Washington, DC 20418

NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Institute of Medicine. The members of the committee responsible for the report were chosen for their special competences and with regard for appropriate balance.

The Institute of Medicine was chartered in 1970 by the National Academy of Sciences to enlist distinguished members of the appropriate professions in the examination of policy matters pertaining to the health of the public. In this, the Institute acts under the Academy's 1863 congressional charter responsibility to be an adviser to the federal government and on its own initiative in identifying issues of medical care, research, and education. Dr. Kenneth I. Shine is president of the Institute of Medicine.

This project was funded by the U.S. Department of Health and Human Services Food and Drug Administration, U.S Department of Agriculture Food Safety and Inspection Service, U.S. Department of Commerce National Marine Fisheries Service, U.S. Environmental Protection Agency, Frito-Lay, Inc.; Hershey Foods; Kellogg Company; Kraft Foods, Inc.; McDonald's Corporation, Monsanto Company; Nabisco, Inc.; Nestlé USA; Proctor & Gamble; and Ross Products. The opinions expressed herein are those of the workshop participants and do not necessarily reflect those of the funders.

International Standard Book No. 0-309-06486-4

Library of Congress Catalog Card Number 99-62305

Additional copies of Enhancing the Regulatory Decision-Making Process for Direct Food Ingredient Technologies: Workshop Summary are available for sale from the
National Academy Press,
2101 Constitution Avenue, N.W., Box 285, Washington, DC 20055. Call (800) 624-6242 or (202) 334-3313 (in the Washington metropolitan area) or visit the NAP's on-line bookstore at www.nap.edu.

For more information about the Institute of Medicine, visit the IOM home page at www2.nas.edu/iom.

Copyright 1999 by the National Academy of Sciences. All rights reserved.

Printed in the United States of America.

The serpent has been a symbol of long life, healing, and knowledge among almost all cultures and religions since the beginning of recorded history. The image adopted as a logotype by the Institute of Medicine is based on a relief carving from ancient Greece, now held by the Staatliche Museen in Berlin.

Suggested Citation:"Front Matter." Institute of Medicine. 1999. Enhancing the Regulatory Decision-Making Approval Process for Direct Food Ingredient Technologies. Washington, DC: The National Academies Press. doi: 10.17226/9453.
×

Food Forum

FERGUS M. CLYDESDALE (Chair),

University Of Massachusetts, Amherst

PERRY L. ADKISSON,

Texas A&M University, College Station

DIANE FEICKERT BIRT,

Iowa State University, Ames

MARSHA N. COHEN,

Hastings College Of The Law, University Of California, San Francisco

JOHN M. CONNOR,

Purdue University, West Lafayette, Indiana

MICHAEL P. DOYLE,

University Of Georgia, Griffin

ROBERT DROTMAN,

Frito-Lay, Inc., Plano, Texas

CHARLES DUNCAN,

Hershey Foods, Hershey, Pennsylvania

VICTOR FULGONI,

Kellogg Company, Battle Creek, Michigan

MICHAEL J. GOLDBLATT,

Mcdonald's Corporation, Oak Brook, Illinois

EDWARD GROTH III,

Consumers Union, Yonkers, New York

RICHARD L. HALL,

Consultant, Baltimore, Maryland

ARTHUR L. HECKER,

Ross Products Division, Abbott Laboratories, Columbus, Ohio

JERRY HJELLE,

Monsanto Company, Deerfield, Illinois

WILLIAM KELLY JONES,

Nabisco Foods Group, East Hanover, New Jersey

EILEEN MADDEN,

Nestlé Usa, Inc., Purchase, New York

RICHARD A. MERRILL,

University Of Virginia School Of Law, Charlottesville

SANFORD A. MILLER,

Graduate School Of Biomedical Sciences, University Of Texas Health Science Center, San Antonio

M. JAYE NAGLE,

Kraft Foods, Glenview, Illinois

MICHAEL W. PARIZA,

University Of Wisconsin, Madison

KEITH TRIEBWASSER,

Procter & Gamble, Cincinnati, Ohio

Ex-Officio Members

E. SPENCER GARRETT,

National Marine Fisheries Service, Pascagoula, Mississippi

LYNN GOLDMAN,

U.S. Environmental Protection Agency, Washington, DC

DAVID A. KESSLER,

Food And Drug Administration, Rockville, Maryland

DAVID R. LINEBACK,

University Of Idaho, Moscow

GEORGE PATERSON,

Health Canada, Ottawa, Ontario

DONNA V. PORTER,

Library Of Congress, Washington, DC

MICHAEL TAYLOR,

United States Department Of Agriculture, Washington, DC

Forum Staff

SANDRA SCHLICKER, Director

KATHERINE J. GORTON, Policy Intern

GERALDINE KENNEDO, Project Assistant

Suggested Citation:"Front Matter." Institute of Medicine. 1999. Enhancing the Regulatory Decision-Making Approval Process for Direct Food Ingredient Technologies. Washington, DC: The National Academies Press. doi: 10.17226/9453.
×

Food And Nutrition Board

CUTBERTO GARZA (Chair),

Division of Nutrition, Cornell University, Ithaca, New York

JOHN W. ERDMAN, JR. (Vice Chair),

Division of Nutritional Sciences, College of Agriculture, University of Illinois at Urbana-Champaign

BENJAMIN CABALLERO,

Center for Human Nutrition, The Johns Hopkins School of Hygiene and Public Health, Baltimore, Maryland

FERGUS M. CLYDESDALE,

Department of Food Science, University of Massachusetts, Amherst

ROBERT J. COUSINS,

Center for Nutritional Sciences, University of Florida, Gainesville

JOHANNA T. DWYER,

Frances Stern Nutrition Center, New England Medical Center Hospital and Departments of Medicine and Community Health, Tufts Medical School and School of Nutrition Science and Policy, Boston, Massachusetts

SCOTT M. GRUNDY,

Center for Human Nutrition, University of Texas Southwestern Medical Center at Dallas

CHARLES H. HENNEKENS,

Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts

ROSS L. PRENTICE,

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington

A. CATHARINE ROSS,

Department of Nutrition, Pennsylvania State University, University Park

ROBERT E. SMITH,

R. E. Smith Consulting, Inc., Newport, Vermont

VIRGINIA A. STALLINGS,

Division of Gastroenterology and Nutrition, The Children's Hospital of Philadelphia, Pennsylvania

Ex-Officio Member

STEVE L. TAYLOR,

Department of Food Science and Technology and Food Processing Center, University of Nebraska, Lincoln

Staff

ALLISON A. YATES, Director

GAIL E. SPEARS, Administrative Assistant

Suggested Citation:"Front Matter." Institute of Medicine. 1999. Enhancing the Regulatory Decision-Making Approval Process for Direct Food Ingredient Technologies. Washington, DC: The National Academies Press. doi: 10.17226/9453.
×

PREFACE

The Institute of Medicine's (IOM's) Food Forum was established in 1993 to allow science and technology leaders in the food industry, top administrators in the federal government, representatives from consumer interest groups, and academicians to discuss and debate food and food safety issues openly and in a neutral setting. The Forum provides a mechanism for these diverse groups to identify possible approaches for addressing food and food safety problems and issues surrounding the often complex interactions among industry, academia, regulatory agencies, and consumers.

On May 6-7, 1997, the Forum convened a workshop titled Enhancing the Regulatory Decision-Making Process for Direct Food Ingredient Technologies. Workshop speakers and participants discussed legal aspects of the direct food additive approval process, changes in science and technology, and opportunities for reform. Two background papers, which can be found in Appendix A and B, were shared with the participants prior to the workshop. The first paper provided a description and history of the legal framework of the food ingredient approval process and the second paper focused on changes in science and technology practices with emphasis placed on lessons learned from case studies. This document presents a summary of the workshop.

The workshop began with Professor Noah's overview of the Food Additives Amendment Act of 1958 and how the U.S. Food and Drug Administration (FDA), over the period of the law's existence, has interpreted and applied the law. This overview was followed by a panel of reactors who spoke about their expectations and perceptions of the congressional and administrative decisions. Members of this panel were lawyers with experience in the legal aspects of the food ingredient approval process and represented consumers, industry, and government. The afternoon session began with an overview of the changes in science and technology and related policy factors that have impacted the FDA's decision-making since the passage of the Food Additives Amendment Act of 1958. Generic lessons learned from experience and case studies about direct food additives were presented. Individuals from government, industry, and consumer groups reacted to the lessons learned from the case studies. An open discussion among speakers and the audience ended the first day's program.

Suggested Citation:"Front Matter." Institute of Medicine. 1999. Enhancing the Regulatory Decision-Making Approval Process for Direct Food Ingredient Technologies. Washington, DC: The National Academies Press. doi: 10.17226/9453.
×

The second day of the workshop focused on the opportunities for reform of the current food ingredient approval system. Speakers from the FDA, industry, Congress, and consumer groups presented their views on the causes of the problems and possible remedies. Open discussion among all participants followed this panel. An agenda and list of participants can be found at the end of the workshop summary.

The purpose of a Forum at the IOM is to foster dialogue and discussion across sectors and institutions. Public forums offer a mechanism for convening individuals from a variety of government, academic, industry, and citizen groups and provide a structured opportunity for open communication among representatives of these groups. The objective, however, is to illuminate issues, not to resolve them. Unlike study committees of the IOM, Forums cannot provide advice or recommendations to any government agency or other organization. Similarly, workshop summaries or other products resulting from forum activities are not intended to reach conclusions or recommendations but, instead, are to reflect the variety of opinions expressed by the participants. The comments in this report represent the views of the workshop participants, as indicated generically in the text. The identification of a speaker as an "industry representative" or a "FDA representative" is not intended to suggest that the individual speaks for that organization or others who work there.

This report has been reviewed in draft form by individuals chosen for their diverse perspectives and technical expertise, in accordance with procedures approved by the National Research Council's Report Review Committee. The purpose of this independent review is to provide candid and critical comments that will assist the Institute of Medicine in making the published report as sound as possible and to ensure that the report meets institutional standards for objectivity, evidence, and responsiveness to the study charge. The content of the final report is the responsibility of the Institute of Medicine and the study committee and not the responsibility of the reviewers. The review comments and draft manuscript remain confidential to protect the integrity of the deliberative process. The forum wishes to thank the following individuals, who are neither officials nor employees of the Institute of Medicine, for their participation in the review of this report: Caroline Smith DeWaal, J.D., Center for Science in the Public Interest; Peter Barton Hutt, LL.M., Covington & Burling; Franklin M. Lowe, D.V.M., Ph.D., Becker College; Judith Stern, Ph.D., University of California at Davis; and Donna U. Vogt, M.A., Congressional Research Service.

While the individuals listed above have provided many constructive comments and suggestions, responsibility for the final content of this report rests solely with the authoring committee and the Institute of Medicine.

Suggested Citation:"Front Matter." Institute of Medicine. 1999. Enhancing the Regulatory Decision-Making Approval Process for Direct Food Ingredient Technologies. Washington, DC: The National Academies Press. doi: 10.17226/9453.
×
Page viii Cite
Suggested Citation:"Front Matter." Institute of Medicine. 1999. Enhancing the Regulatory Decision-Making Approval Process for Direct Food Ingredient Technologies. Washington, DC: The National Academies Press. doi: 10.17226/9453.
×
This page in the original is blank.
Suggested Citation:"Front Matter." Institute of Medicine. 1999. Enhancing the Regulatory Decision-Making Approval Process for Direct Food Ingredient Technologies. Washington, DC: The National Academies Press. doi: 10.17226/9453.
×
PageR1
Suggested Citation:"Front Matter." Institute of Medicine. 1999. Enhancing the Regulatory Decision-Making Approval Process for Direct Food Ingredient Technologies. Washington, DC: The National Academies Press. doi: 10.17226/9453.
×
PageR2
Suggested Citation:"Front Matter." Institute of Medicine. 1999. Enhancing the Regulatory Decision-Making Approval Process for Direct Food Ingredient Technologies. Washington, DC: The National Academies Press. doi: 10.17226/9453.
×
PageR3
Suggested Citation:"Front Matter." Institute of Medicine. 1999. Enhancing the Regulatory Decision-Making Approval Process for Direct Food Ingredient Technologies. Washington, DC: The National Academies Press. doi: 10.17226/9453.
×
PageR4
Suggested Citation:"Front Matter." Institute of Medicine. 1999. Enhancing the Regulatory Decision-Making Approval Process for Direct Food Ingredient Technologies. Washington, DC: The National Academies Press. doi: 10.17226/9453.
×
PageR5
Suggested Citation:"Front Matter." Institute of Medicine. 1999. Enhancing the Regulatory Decision-Making Approval Process for Direct Food Ingredient Technologies. Washington, DC: The National Academies Press. doi: 10.17226/9453.
×
PageR6
Suggested Citation:"Front Matter." Institute of Medicine. 1999. Enhancing the Regulatory Decision-Making Approval Process for Direct Food Ingredient Technologies. Washington, DC: The National Academies Press. doi: 10.17226/9453.
×
PageR7
Page viii Cite
Suggested Citation:"Front Matter." Institute of Medicine. 1999. Enhancing the Regulatory Decision-Making Approval Process for Direct Food Ingredient Technologies. Washington, DC: The National Academies Press. doi: 10.17226/9453.
×
PageR8
Next: Workshop Summary »
Enhancing the Regulatory Decision-Making Approval Process for Direct Food Ingredient Technologies Get This Book
×
Buy Paperback | $51.00 Buy Ebook | $40.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

The Institute of Medicine's (IOM's) Food Forum was established in 1993 to allow science and technology leaders in the food industry, top administrators in the federal government, representatives from consumer interest groups, and academicians to discuss and debate food and food safety issues openly and in a neutral setting. The Forum provides a mechanism for these diverse groups to identify possible approaches for addressing food and food safety problems and issues surrounding the often complex interactions among industry, academia, regulatory agencies, and consumers.

On May 6-7, 1997, the Forum convened a workshop titled Enhancing the Regulatory Decision-Making Process for Direct Food Ingredient Technologies. Workshop speakers and participants discussed legal aspects of the direct food additive approval process, changes in science and technology, and opportunities for reform. Two background papers, which can be found in Appendix A and B, were shared with the participants prior to the workshop. The first paper provided a description and history of the legal framework of the food ingredient approval process and the second paper focused on changes in science and technology practices with emphasis placed on lessons learned from case studies. This document presents a summary of the workshop.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!